SEC Form 4 · accession 0001013606-18-000033
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
Mar 27, 2018
Accepted (ET)
Mar 28, 2018 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2018 | M | 250,000 | $2.67 | A | 838,659 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $2.67 | Mar 27, 2018 | M | 250,000 | D | May 12, 2009 | May 12, 2018 | Common Stock | 250,000 | 155,381 | D |